Inositol 12 g per day was added to ongoing anti-Parkinson therapy in a controlled randomized cross-over design in nine patients. No therapeutic eect was found.
Parkinson's disease is not a long-latency illness
β Scribed by Dr. P. K. Morrish
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- English
- Weight
- 608 KB
- Volume
- 12
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## __Objective__ The __UCHLβ1__ gene is widely cited as a susceptibility factor for sporadic Parkinson's disease (PD). The strongest evidence comes from a metaβanalysis of small studies that reported the S18Y polymorphism as protective against PD, after pooling studies of white and Asi
## Abstract The consistent findings of decreased levels of the major antioxidant glutathione in substantia nigra of patients with idiopathic Parkinson's disease (PD) has provided most of the basis for the oxidative stress hypothesis of the etiology of PD. To establish whether a nigral glutathione d
## Abstract Mutations in __LRRK2__ were first reported as causing Parkinson's disease (PD) in late 2004. Since then, approximately a dozen __LRRK2__ substitutions have been identified that are believed to be pathogenic mutations. The substitution of adenine for guanine at nucleotide 4541 (4541G>A)
Lower leg rest tremor is an uncommon symptom of neurological disease. Review of the files of 16 patients who presented with lower leg tremor (average age 58 +/- 16 years; average disease duration 6.8 +/- 8.5 years) yielded a diagnosis of Parkinson's disease (PD) in 5 and probable multiple system atr